EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MOndAy 24 JUnE <strong>2013</strong> - AFTERNOON<br />
14:00 - 15:30 Main session santorini<br />
Reduce ICD shocks: improve quality <strong>of</strong> life<br />
Connecting Continents - south America - <strong>EHRA</strong><br />
Chairpersons: C. Wolpert (ludwigsburg, dE); R. Oyarzun (santiago, Cl)<br />
transforming<br />
14:00 inappropriate shocks: reasons and prevention. 442<br />
W. Uribe (Medellin, CO)<br />
14:22 Reduction <strong>of</strong> appropriate shocks: role <strong>of</strong> optimal device programming. 443<br />
I. Fernandez Lozano (Madrid, ES)<br />
14:45 Reduction <strong>of</strong> appropriate shocks: role <strong>of</strong> drug therapy. 444<br />
O. Bazzino (Montevideo, UY)<br />
15:07 Reduction <strong>of</strong> appropriate shocks: role <strong>of</strong> catheter ablation. 445<br />
C. Carbucicchio (Milan, IT)<br />
14:00 - 15:30 Oral Abstract session Hydra<br />
Oral Abstract Session: outcomes in CRT<br />
Chairpersons: J.C. daubert (Rennes, fR); l. Kappenberger (lausanne, CH)<br />
14:00 Cardiac resynchronisation therapy in patients with atrial fibrillation: the CERTIFY study 446<br />
M. Gasparini, C. Leclercq, M. Lunati, M. Landolina, A. Auricchio, M. Santini, G. Boriani,<br />
A. Proclemer, A. Curnis, F. Leyva (Rozzano, Pavia, Rome, Bologna, Udine and<br />
Brescia, IT; Rennes, FR; Lugano, CH; Birmingham, GB)<br />
14:15 differences in occurrence <strong>of</strong> device therapy in echocardiographic responders and<br />
super responders to cardiac resynchronisation therapy 447<br />
A.C. Van Derh Heijden, U. Hoke, C.J.W. Borleffs, J. Thijssen, J.B. Van Rees,<br />
E.T. Van Der Velde, M.J. Schalij, L. Van Erven (Leiden, NL)<br />
14:30 Is CRT-P beneficial in heart failure patients with LBBB and LVEF 36-50%? The design<br />
<strong>of</strong> the MiRAClE Ef study. 448<br />
C. Linde, A. Curtis, G. Fonarow, K. Lee, W. Little, A. Tang, F. Levya, S. Momomura,<br />
T. Bergmann, M. Cowie (Stockholm, SE; Buffalo, Los Angeles, Durham, NC,<br />
Winston-salem and Minneapolis, US; Victoria, CA; Birmingham and London, GB; Saitama, JP)<br />
14:45 Right ventricular to left ventricular interlead sensed electrical delay predicts<br />
all-cause mortality in CRt patients 449<br />
V. Kutyifa, L. Geller, E. Zima, S.Z. Szilagyi, G. Szucs, V.K. Nagy, A. Kosztin, L. Molnar,<br />
G. Szeplaki, B. Merkely (Budapest, HU)<br />
15:00 Effect <strong>of</strong> intrinsic conduction delays on clinical outcomes with CRt: analysis <strong>of</strong> the<br />
adaptive CRt trial 450<br />
B. Lemke, A. Kloppe, D. Birnie, K. Aonuma, H. Krum, K.L.L. Lee, M. Gasparini,<br />
R. Starling, A. Sambelashvili, D.O. Martin (Luedenscheid and Bochum, DE; Ottawa,<br />
CA; Tsukuba, JP; Melbourne, AU; Hong Kong, HK; Rozzano, IT; Cleveland and Mounds View, US)<br />
15:15 decreased rate <strong>of</strong> left ventricular lead deactivation and replacement associated with<br />
use <strong>of</strong> a quadripolar lV lead 451<br />
M.P. Turakhia, M.R. Gold, A. Fischer, L.S. Sloman, C. Kumar, N. Dalal, K. Ryu, J.D. Snell,<br />
M. Cao (Palo Alto, Charleston, Sylmar, California and Los Angeles, US)<br />
81<br />
monday<br />
sessions
Change language